Global Pharmatech, Inc.
GBLP · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $33 | $30 | $16 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $325 | $328 | $348 | $195 |
| Inventory | $28 | $28 | $26 | $26 |
| Other Curr. Assets | $2 | $1 | $1 | $1 |
| Total Curr. Assets | $389 | $387 | $390 | $250 |
| Property Plant & Equip (Net) | $82 | $84 | $91 | $95 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $100 | $0 | $101 | $101 |
| Long-Term Investments | $181 | $0 | $5 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $281 | $0 | $0 |
| Total NC Assets | $364 | $365 | $197 | $195 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $752 | $752 | $588 | $446 |
| Liabilities | – | – | – | – |
| Payables | $429 | $430 | $432 | $306 |
| Short-Term Debt | $90 | $80 | $90 | $80 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $185 | $181 | $172 | $168 |
| Other Curr. Liab. | $114 | $181 | $188 | $137 |
| Total Curr. Liab. | $818 | $872 | $883 | $691 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $818 | $872 | $883 | $691 |
| Equity | – | – | – | – |
| Pref Stock | $10 | $10 | $10 | $10 |
| Common Stock | $154 | $153 | $158 | $158 |
| Retained Earnings | -$12,239 | -$12,243 | -$12,170 | -$12,164 |
| AOCI | $70 | $21 | -$22 | $21 |
| Other Equity | $11,939 | $11,939 | $11,730 | $11,730 |
| Total Equity | -$66 | -$120 | -$295 | -$245 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $752 | $752 | $588 | $446 |
| Net Debt | $57 | $51 | $75 | $51 |